Patents Assigned to UVLrx Therapeutics, Inc.
  • Patent number: 10512788
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: December 24, 2019
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter, Victor Josef Scheeren
  • Patent number: 10261277
    Abstract: An optical device for illuminating the vasculature of a mammal using ultraviolet, visible, and/or infrared light is described. The optical device includes an optical fiber encased in a biocompatible sheath, and is dimensioned to lie within an intravascular catheter. When placed within a vascular space and coupled with a suitable light source the optical device illuminates the vascular space and its contents. The faces of the optical fiber are configured to optimize the capture of ultraviolet, visible, and/or infrared light from a light source without the use of active optics.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: April 16, 2019
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter
  • Patent number: 9827438
    Abstract: A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 28, 2017
    Assignee: UVLRX THERAPEUTICS, INC.
    Inventors: Scot Johnson, Michael Harter, Victor Josef Scheeren
  • Patent number: 9814899
    Abstract: Systems and methods for illumination of a vascular space and its contents using an electromagnetic energy source that supplies a plurality of wavelengths ranging from ultraviolet to infrared are shown. Illumination can be performed using multiple wavelengths, simultaneously or sequentially, and can be performed in accordance with a protocol where an initial illumination produces an effect that is at least partially reversed by a subsequent illumination. Illumination protocols can be stored on a database and accessed via a user interface displayed on the electromagnetic energy source. The database can be used to store data related to performance of system components, and such data can be used to override or modify an illumination protocol.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 14, 2017
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter
  • Patent number: D757955
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: May 31, 2016
    Assignee: UVLrx Therapeutics, Inc.
    Inventors: Scot Johnson, Michael Harter